LEVELS OF C-REACTIVE PROTEIN AND TOTAL PROTEIN IN MALARIA AND HIV CO INFECTED PREGNANT WOMEN, ATTENDING THE ANTENATAL CLINIC OF NNAMDI AZIKIWE UNIVERSITY TEACHING HOSPITAL, NNEWI, SOUTHEASTERN NIGERIA.
DOI:
https://doi.org/10.61841/xhkt8k29Abstract
The goal of the study was to quantify the levels of C reactive protein and protein in pregnant HIV-positive malaria-infected women. Pregnant women in HIV stages 1 and 2 who were 18 to 40 (36.98 + 5.49) years old participated in the study. The participant groups consisted of 80 HIV-positive pregnant women with 40 co-infected with malaria and 80 HIV-negative pregnant women with 40 co-infected with malaria. Blood samples were obtained from participants for the thick and thin film methods of counting and identifying malaria parasites and the immunochromatographic method of determining HIV status. The total protein content of the serum was determined using the Biuret method, and the violetcoloured solution that was produced was measured spectrophotometrically at 540 nm. The Enzyme linked Immunosorbent assay using the Human CRP kit method was employed to measure the level of CRP in the participants’ blood sample and the developed yellow coloured solution read at 450 nm using a spectrophotometer. In all cases, there was a statistically significant difference in protein and CRP levels between the HIV seropositive group with malaria infection (p<0.05) and HIV seropositive group without malaria infection. The mean protein and CRP level of HIV-positive pregnant women who have malaria infection was statistically lower than that of HIV-positive pregnant women who do not have malaria but statistically higher than those of HIV-negative pregnant women with and without malaria infection. The study suggests that pregnant HIV-positive women do experience a heightened increase in protein and CRP levels majorly due to HIV. However, malaria infection also contributes to the level of increase seen in these parameters in pregnant women with the coinfection.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Journal of Advance Research in Pharmacy and Biological Science (ISSN 2208-2360)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.